Actinel Solution
NDC Package 63102-101-16
Package Information
Actinel (dextromethorphan hbr, guaifenesin, pseudoephedrine hcl) solution is • Adults and children 12 years of age and over: Take 1 to 2 teaspoonfuls every 6 hours if needed, not to exceed 8 teaspoonfuls in 24 hours, or as directed by a doctor.• Children 6-12 years, Take ½ to 1 teaspoonful every 6 hours if needed, do not exceed 4 teaspoonfuls in 24 hours, or as directed by a doctor.• Children under 6 years of age: consult a doctor. This formulation utilizes a solution delivery system. Marketed by Actipharma, Llc, this product is identified by NDC 63102-101 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1098227 - dextromethorphan HBr 15 MG / guaiFENesin 200 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution
- RxCUI: 1098227 - dextromethorphan hydrobromide 3 MG/ML / guaifenesin 40 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution
- RxCUI: 1098227 - dextromethorphan hydrobromide 15 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 63102 - Actipharma, Llc
- 63102-101 - Actinel
- 63102-101-16 - 474 mL in 1 BOTTLE
- 63102-101 - Actinel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63102-101-16 identifies a specific commercial package of 474 ml in 1 bottle of Actinel, a human over the counter drug labeled by Actipharma, Llc. This product is billed per "ML" milliliter and contains an estimated amount of 474 billable units per package. This solution is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin; pseudoephedrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actipharma, Llc on September 24, 2014. The current certification is valid through December 31, 2026.
How is this Actipharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63102010116. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 474 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.